Cohort Description The Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) is a multi-center, observational, longitudinal case-control study designed to guide future development of therapies for COPD. SPIROMICS has recruited 2,983 COPD cases and controls, 40-80 years old with 20+ pack-years of smoking at 12 US sites in 2010–2015.

Collaborative Cohort of Cohorts for COVID-19 Research (C4R):    Subpopulations and Intermediate Outcome Measures in COPD Study    (SPIROMICS)

COVID-19 study on BDC (1,579 participants)

phs002909 — Collaborative Cohort of Cohorts for COVID-19 Research (C4R):    Subpopulations and Intermediate Outcome Measures in COPD Study    (SPIROMICS)

Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)

Description

Applying For Access

Summary